ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Arch Therapeutics Inc

Arch Therapeutics Inc (0HHJ)

0.434
0.00
( 0.00% )
Updated: 19:00:00

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.434
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
0.434 52 Week Range 0.434
Market Cap
Previous Close
0.434
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
3,094,000
Dividend Yield
-
PE Ratio
-0.09
Earnings Per Share (EPS)
-2.26
Revenue
76k
Net Profit
-6.98M

About Arch Therapeutics Inc

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Carson City, Nevada, USA
Founded
-
Arch Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker 0HHJ. The last closing price for Arch Therapeutics was $0.43. Over the last year, Arch Therapeutics shares have traded in a share price range of $ 0.434 to $ 0.434.

Arch Therapeutics currently has 3,094,000 shares outstanding. The market capitalization of Arch Therapeutics is $1.34 million. Arch Therapeutics has a price to earnings ratio (PE ratio) of -0.09.

0HHJ Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.4340.4340.43400DE
4000.4340.4340.43400DE
12000.4340.4340.43400DE
26000.4340.4340.43400DE
52000.4340.4340.43400DE
156000.4340.4340.43400.434DE
260000.4340.4340.43410.434DE

0HHJ - Frequently Asked Questions (FAQ)

What is the current Arch Therapeutics share price?
The current share price of Arch Therapeutics is $ 0.434
How many Arch Therapeutics shares are in issue?
Arch Therapeutics has 3,094,000 shares in issue
What is the market cap of Arch Therapeutics?
The market capitalisation of Arch Therapeutics is USD 1.34M
What is the 1 year trading range for Arch Therapeutics share price?
Arch Therapeutics has traded in the range of $ 0.434 to $ 0.434 during the past year
What is the PE ratio of Arch Therapeutics?
The price to earnings ratio of Arch Therapeutics is -0.09
What is the cash to sales ratio of Arch Therapeutics?
The cash to sales ratio of Arch Therapeutics is 8.13
What is the reporting currency for Arch Therapeutics?
Arch Therapeutics reports financial results in USD
What is the latest annual turnover for Arch Therapeutics?
The latest annual turnover of Arch Therapeutics is USD 76k
What is the latest annual profit for Arch Therapeutics?
The latest annual profit of Arch Therapeutics is USD -6.98M
What is the registered address of Arch Therapeutics?
The registered address for Arch Therapeutics is 769 BASQUE WAY, SUITE 300, CARSON CITY, NEVADA, 89706
What is the Arch Therapeutics website address?
The website address for Arch Therapeutics is www.archtherapeutics.com
Which industry sector does Arch Therapeutics operate in?
Arch Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STAFStaffline Group Plc
25.70p
(36.70%)
2.15M
CELCeladon Pharmaceuticals Plc
20.50p
(24.24%)
189.63k
SYMESupply@me Capital Plc
0.0037p
(23.33%)
151.85M
EUAEurasia Mining Plc
3.30p
(16.81%)
50.99M
TUNTungsten West Plc
3.125p
(13.64%)
851.69k
AGTAAgriterra Ld
0.60p
(-25.00%)
2.66k
SCGLSealand Capital Galaxy Limited
5.25p
(-23.91%)
6.7M
ROQRoquefort Therapeutics Plc
2.65p
(-20.90%)
9.15M
MTCMothercare Plc
3.50p
(-16.67%)
97.4k
FCHFunding Circle Holdings Plc
104.50p
(-16.40%)
8.68M
INSPInspirit Energy Holdings Plc
0.0031p
(10.71%)
558.5M
MSMNMosman Oil And Gas Limited
0.0425p
(0.00%)
440.34M
NTVONativo Resources Plc
0.0017p
(-5.56%)
288.45M
VODVodafone Group Plc
65.28p
(-6.77%)
244.15M
EMEEmpyrean Energy Plc
0.1675p
(11.67%)
207.31M

Discussion

View Full Feed
kazzy kazzy 55 seconds ago
Avocet 1 made the list too. 2036.
TGLO
CK-verse CK-verse 56 seconds ago
$HHSE partnering-with $DJT...MASSIVE-UPSIDE for BOTH companies:

https://www.otcmarkets.com/otcapi/company/financial-report/419415/content

a). TRUMP MEDIA & TECHNOLOGIES GROUP – In respect of access provided to Barr McClellan and
Hannover House to key Trump campa
DJT HHSE MILLION
Helloman1 Helloman1 1 minute ago
OK so now that the pumpers sold all their 0001s does anyone know what ticker they pumping now? Asking for a friend 😆
GRLF
TheRealMrPirate TheRealMrPirate 1 minute ago
Truely dumb,♿️ why don't you let the adults handle the conversation?
LakeshoreLeo1953 LakeshoreLeo1953 2 minutes ago
I currently am exposed near $1 above yesterday's close.
As I lick my wounds more often than many $8 would be a pain level
I would consider intolerable in the short term.

The OVERALL performance within my portfolio of AVXL since OTC
can absorb that decline ( and si
AVXL
DiscoverGold DiscoverGold 2 minutes ago
Technical Overbought/Sold Composite
By: Isabelnet | February 4, 2025

• S&P 500

With a reading of 73.44, the US stock market has moved out of very overbought territory, potentially signaling an upcoming period of consolidation.

pbs.twimg.com/m
biowin biowin 2 minutes ago
If Bioamber's contracts were not transferred to the purchaser it means that they were using Bioamber's license and were still active but not comleted, also Mitsui gave up its equity in Bioamber Sarnia to have another agreement which was to have access to distribute Bioamber's biosuccinic acic from
pegs1 pegs1 3 minutes ago
Walrus
You said that Coretec hasn’t used all of their raised funds yet. That they may purchase additional shares of KIB Energy. Maybe they should use those funds to hire additional auditors! Then they could get the 10Q done!
CRTG
hibarb hibarb 3 minutes ago
Your report you are showing is dated from Year 2012. It is now Year 2025.
GNCP
jem1 jem1 3 minutes ago
Sorry..fourclose..it..is..moving..to..OTCBB
DBMM
Gmenfan Gmenfan 3 minutes ago
And yet the deep blue state of NY will keep voting the same way!!!
chereb19 chereb19 4 minutes ago
HA

https://investorshub.advfn.com/uimage/uploads/2024/11/11/gaknodoc1.JPG
RDGL
Paulness Paulness 4 minutes ago
NEWS -- Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare

https://media.zenfs.com/en/business-wire.com/21936ae9018d70756aa8ad67d58b935d

CARLSBAD, Calif., February 04, 2025--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and
LCTX
Buckey Buckey 4 minutes ago
On the fentanyl Zsar. Been thinking the obvious choice would of been Mr. Lahey and even though he has passed away and Trump may not notice but for full transparency Randy is the obvious and only choice. Very similar job as assistant "Trailer Park Supervisor"
https://smartcdn.gprod.postmedi
AlwaysOptimistic AlwaysOptimistic 4 minutes ago
That's great news. This project has been stuck in the mud until now. It took a change of admin to get things moving again. Go figure.
NB
glenn1919 glenn1919 4 minutes ago
EVAX.......IVVD.....LITM......KAPA.......................https://stockcharts.com/h-sc/ui?s=IVVD&p=D&yr=0&mn=3&dy=0&id=p11960084343
EVAX IVVD KAPA
Real McCoy Real McCoy 4 minutes ago
It was both. They got a deposit and then the rest for an aggregate upfront amount of 4.34M.
DiscoverGold DiscoverGold 5 minutes ago
Gold $GLD - Breaking New Highs!!!
By: Sahara | February 3, 2025

• $GOLD $GLD - Breaking New Highs!!!

Nearing that $2850 Target. Yet needs to get above that Mid-Channel Band...

pbs.twimg.com/media/Gi4rc9QXUAA5fS0?format=jpg&name=large
GLD GOLD
manibiotech manibiotech 5 minutes ago
But I will be ok with paid pumpers and apologists.
Let's do a roll call starting with Doc Logic
NWBO
Gmenfan Gmenfan 5 minutes ago
Mornin' K². Let's hope that Trump sees to it that Mexico and Canada walk the walk and not just talk the talk!!
axelvento axelvento 5 minutes ago
Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance

Full-Year 2024 Revenues of $63.6 Billion, Reflecting 7% Year-over-Year Operational Growth


https://s28.q4cdn.com/781576035/files/doc_financials/2024/q4/Q4-2024-PFE-Earnings-Release-Final.pdf
PFE
glenn1919 glenn1919 6 minutes ago
NXU.......ZONE.......AZTR..........MULN.....................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
AZTR MULN NXU
TheRealMrPirate TheRealMrPirate 6 minutes ago
Defunct Delaware 4612067 / FKA bioaq
Your assumption is incorrect, KKR had no connection to former BioAmber nor do they own the technology.
LCY Biotechnology purchased all assets including rights / patents / IP / etc - clearly documented.
LCY Chemical didn't "need" KKR, to be ab
$b_rich$ $b_rich$ 6 minutes ago
ETST 8k:
https://www.otcmarkets.com/filing/html?id=18152450&guid=yM0-kpyrrlxjJth
ETST